Volume : 13, Issue : 01, January – 2026
Title:
A PROSPECTIVE OBSERVATIONAL STUDY ON PREVALENCE AND MANAGEMENT OF HEPATITIS AT A TERTIARY CARE TEACHING HOSPITAL
Authors :
Hafsa Jabeen*, Rubiya Iqbal, Ayesha Bee, Sana Bint Hamed Al Kaseri, Mahe Naaz Sultana, Dr. Syeda Rana Nikhat
Abstract :
Background: This article focuses on viral hepatitis, which accounts for more than 50% of cases of acute hepatitis, mostly in the emergency department setting. Hepatitis is a general term for inflammation of the liver and can be caused by a variety of infectious (such as bacterial, fungal, viral, and parasitic organisms) and non-infectious (such as alcohol, drugs, autoimmune diseases, and metabolic diseases).Three viruses: hepatitis A (HAV), hepatitis B (HBV), and hepatitis C (HCV). All three of these viruses can cause an acute illness that manifests as jaundice, malaise, exhaustion, nausea, and stomach pain. Furthermore, chronic infection can result from acute HBV and HCV infection. Chronically infected patients may develop cirrhosis and hepatocellular carcinoma (HCC). Additionally, carriers of chronic hepatitis are still contagious and can spread the illness for many years.
Aims and Objectives : To study the prevalence and management of hepatitis in the general medicine department and to analyse the prescribing patterns , and immunoglobulin administration for various types of hepatitis.
Methodology: It is a prospective and observational study carried out over a period of six months at Osmania General Hospital Afzal Gunj , Hyderabad. Patients of both sex who are diagnosed with hepatitis age above 18 years were selected for the study.A total of 100 cases were collected using a predesigned data collection form and statistical approach to evaluate the prevalence and management of hepatitis.
Results: There is a predominance of hepatitis in male ( 86%) in the study population. More cases are recorded for patients below ( 41-50 ) years of age group. Whereas, the diagnosis was made on the basis of laboratory findings and serological results which reveal viral hepatitis (A-E). Moreover, the clinical manifestation were found to be jaundice , yellowish discolouration of eyes and skin , abdominal pain. The commonly prescribed drugs for hepatitis were ceftriaxone , pantoprazole, metronidazole , furosemide , ampicillin , L-ornithine L-aspartate and meropenem.
Conclusion : In the present study 100 cases of hepatitis were recorded and various prescription patterns were observed, however there is a predominance of alcoholic hepatitis in male. Majority of the cases are recorded in patients below 50 years of age, and other risk factors that trigger the disease condition include smoking , alcohol abuse for hepatitis. Likewise, laboratory investigations were carried out in most cases, and there was a lack or standard treatment pattern was recorded.
Keywords : Hepatitis , Jaundice , Immunoglobulins , Cirrhosis , Hepatocellular Carcinoma.
Cite This Article:
Please cite this article in press Hafsa Jabeen et al., A Prospective Observational Study On Prevalence And Management Of Hepatitis At A Tertiary Care Teaching Hospital, Indo Am. J. P. Sci, 2026; 13(01).
REFERENCES:
1. Centers for disease control and prevention (CDC). Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention.[ internet] Available from: http://www.cdc.gov/hepatitis. Accessed on March 8,2023.
2. Previsani N, Lavanchy D, World Health Organization. Hepatitis B (WHO/CDS/CSR/LYO/2002.2). 2002.
3. Fonseca JC. [History of viral hepatitis]. Rev Soc Bras Med Trop. 2010;43:322-330. [PubMed] [DOI] [Cited in This Article: 1] [Article Influence: 0.8] [Reference Citation Analysis (5)] https://doi.org/10.1590/S0037-86822010000300022
4. Martin NA. The discovery of viral hepatitis: a military perspective. J R Army Med Corps. 2003;149:121-124. [PubMed] [Cited in This Article: 1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] http://dx.doi.org/10.1136/jramc-149-02-04
5. R.ALAGAPPAN, Manual of Practical Medicine. Fifth edition; Kundli; JAYPEE BROTHERS MEDICAL PUBLISHERS; Sanat printers;2014.
6. National Library of Medicine(NIH), National Center for Biotechnology InformationCompany(ncbi) ; Parth Mehta; Anil Kumar Reddy Reddivari.hepatitis- Statpearls [internet] . https://www.ncbi.nlm.nih.gov/ accessed on October 24,2022.
7. R.ALAGAPPAN, Manual of Practical Medicine. Fifth edition; Kundli; JAYPEE BROTHERS MEDICAL PUBLISHERS; Sanat printers;2014.
8. Rodger Walker and Cate whittlesea, Clinical pharmacy and therapeutics 5th edition;2012:240-242.
9. Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006. 3 (2):47-52.
10. Castaneda D, Gonzalez AJ, Alomari M, Tandon K, Zervos XB. From hepatitis A to E: A critical review of viral hepatitis. World J Gastroenterol 2021; 27(16): 1691-1715 [PMID: 33967551 DOI: https://dx.doi.org/10.3748/wjg.v27.i16.1691]
11. Emergency care institute ,New south wales , / Clinical/clinical-tools/gastroenterology/hepatiits https://aci.health.nsw.gov.au/networks/eci/about
12. Koff RS. Feinstone SM, Kapikian AZ, Purcell RH. Hepatitis A: detection by immune electron microscopy of a virus like antigen associated with acute illness [Science 1973;182:1026-1028]. J Hepatol. 2002;37:2-6. [PubMed] DOI: https://doi.org/10.1016/S0168-8278(02)00169-1
13. World Health Organization. Hepatitis A. [cited 19 January 2021]. In: World HealthOrganization [Internet]. Available from: https://www.who.int/home https://www.who.int/news-room/fact-sheets/detail/hepatitis-a.
14. Mackinney-Novelo I, Barahona-Garrido J, Castillo-Albarran F, Santiago-Hernández JJ, Méndez-Sánchez N, Uribe M, Chávez-Tapia N. Clinical course and management of acute hepatitis A infection in adults. Ann Hepatol. 2012;11:652-657. [PubMed] [Cited in This Article: 2] https://pubmed.ncbi.nlm.nih.gov/22947525/
15. European Centre for Disease Prevention and Control. Epidemiological update: Hepatitis A outbreak in the EU/EEA mostly affecting men who have sex with men. [cited 28 July 2020]. In: European Centre for Disease Prevention and Control [Internet].
16. National Center for Health Statistics. Health Data Interactive. [cited 30 December 2020]. In: Centers for Disease Control and Prevention [Internet]. In: Available from: https://www.cdc.gov/nchs/hdi.htm. [Cited in This Article: 1]
17. Liaw YF, Yang CY, Chu CM, Huang MJ. Appearance and persistence of hepatitis A IgM antibody in acute clinical hepatitis A observed in an outbreak. Infection. 1986;14:156-158. [PubMed] [DOI] [Cited in This Article: 1] https://link.springer.com/article/10.1007/BF01645253#citeas
18. Lemon SM, Binn LN, Marchwicki R, Murphy PC, Ping LH, Jansen RW, Asher LV, Stapleton JT, Taylor DG, LeDuc JW. In vivo replication and reversion to wild type of a neutralization-resistant antigenic variant of hepatitis A virus. J Infect Dis. 1990;161:7-13. [PubMed] [Cited in This Article: 1]https://doi.org/10.1093/infdis/161.1.7
19. Kryger P, Christoffersen P. Liver histopathology of the hepatitis A virus infection: a comparison with hepatitis type B and non-a, non-b. J Clin Pathol. 1983;36:650-654. [PubMed] http://dx.doi.org/10.1136/jcp.36.6.650
20. Centers for Disease Control and Prevention. Widespread person-to-person outbreaks of hepatitis A across the United States. [cited 28 July 2020]. In: Centers for Disease Control and Prevention [Internet]. Available from: https://www.cdc.gov/hepatitis/outbreaks/2017March-HepatitisA.htm. [Cited in This Article: 2]
21. Centers for Disease Control and Prevention. Hepatitis A Questions and Answers for Health Professionals. [cited 28 July 2020]. In: Centers for Disease Control and Prevention [Internet]. Available from: https://www.cdc.gov/hepatitis/hav/havfaq.htm#vaccine. [Cited in This Article: 1] https://pubmed.ncbi.nlm.nih.gov/15889006/
22. Taylor RM, Davern T, Munoz S, Han SH, McGuire B, Larson AM, Hynan L, Lee WM, Fontana RJ; US Acute Liver Failure Study Group. Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes. https://doi.org/10.1002/hep.21439
23. Jung DH, Hwang S, Lim YS, Kim KH, Ahn CS, Moon DB, Ha TY, Song GW, Park GC, Lee SG. Outcome comparison of liver transplantation for hepatitis A-related vs hepatitis B-related acute liver failure in adult recipients. Clin Transplant. 2018;32. [PubMed] https://doi.org/10.1111/ctr.13140
24. https://www.hepb.org/prevention-and-diagnosis/prevention-tips/
25. Mindie H. Nguyen, Grace Wong, Edward Gane, Jia-Horng Kao, Geoffrey Dusheiko Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy; ASM Journals, Clinical Microbiology Reviews/vol.33 No.2 https://doi.org/10.1128/cmr.00046-19
26. https://en.m.wikipedia.org/wiki/File:Hepatitis_B_serology.jpg
27. Prasidthrathsint K, Stapleton JT. Laboratory Diagnosis and Monitoring of Viral Hepatitis. Gastroenterol Clin North Am. 2019;48:259-279. [PubMed] [DOI] https://doi.org/10.1016/j.gtc.2019.02.007
28. Park JS, Gayam V, Pan CQ. Review article: preventing hepatitis B graft infection in hepatitis B patients after liver transplantation: immunoglobulin vs anti-virals. Aliment Pharmacol Ther. 2020;52:944-954. [PubMed] [DOI] https://doi.org/10.1111/apt.15999
29. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333–42. doi:10.1002/hep.26141
30. Murphy EL, Bryzman SM, Glynn SA, Ameti DI, Thomson RA, Williams AE, et al. Risk factors for hepatitis C virus infection in United States Blood Donors. Hepatology. 2000;31(3):756–62. doi:10.1002/hep.510310329
31. Zein NN. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev. 2000;13:223-235. [PubMed] [DOI] [Cited in This Article: 1] [Internet]. [cited 2023 Jul 11]. Available from: https://journals.asm.org/doi/10.1128/CMR.13.2.223
32. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V, Yamamoto AM, Camproux AC, Hausfater P, Musset L, Veyssier P, Raguin G, Piette JC. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d’Etude et de Recherche en Medecine Intern et Maladies Infectieuses sur le Virus de l’Hepatite C. Medicine (Baltimore). 2000;79:47-56. [PubMed] [DOI] [Cited in This Article: 1]
33. Thein H-H, Yi Q, Dore GJ, Krahn MD. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression. Hepatology. 2008;48(2):418–31. doi:10.1002/hep.22375
34. Cholankeril G, Ahmed A. Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the United states. Clinical Gastroenterology and Hepatology. 2018;16(8):1356–8. doi:10.1016/j.cgh.2017.11.045
35. Mederacke I, Wedemeyer H, Ciesek S, Steinmann E, Raupach R, Wursthorn K, et al. Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay. Journal of Clinical Virology. 2009;46(3):210–5. doi:10.1016/j.jcv.2009.08.014
36. Doshi RK, Ruben M, Drezner K, Lachmann A, Kuo I, Chanes-Mora P, et al. Knowledge, attitudes, and behaviors related to hepatitis C screening and treatment among health care providers in Washington, DC. Journal of Community Health. 2020;45(4):785–94. doi:10.1007/s10900-020-00794-z
37. Farci P. Delta hepatitis: an update. J Hepatol. 2003;39 Suppl 1:S212-S219. [PubMed] [DOI] [Cited in This Article: 1] [Cited by in Crossref: 168] [Cited by in F6Publishing: 176] [Article Influence: 8.8] [Reference Citation Analysis (0)
38. Rizzetto M, Canese MG, Aricò S, Crivelli O, Trepo C, Bonino F, Verme G. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers; BMJ Journals; volume 18,issue 12; http://dx.doi.org/10.1136/gut.18.12.997
39. Yurdaydin C, Keskin O, Kalkan Ç, Karakaya F, Çalişkan A, Karatayli E, Karatayli S, Bozdayi AM, Koh C, Heller T, Idilman R, Glenn JS. Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study.; Hepatology 67(4):p 1224-1236, April 2018. ;DOI: 10.1002/hep.29658
Bazinet M, Pântea V, Cebotarescu V, Cojuhari L, Jimbei P, Albrecht J, Schmid P, Le Gal F, Gordien E, Krawczyk A, Mijočević H, Karimzadeh H, Roggendorf M, Vaillant A. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial. Lancet Gastroenterol Hepatol. 2017;2:877-889 volume 2, issue 12; September 27,2017.
40. Cangin C, Focht B, Harris R, Strunk JA. Hepatitis E seroprevalence in the United States: Results for immunoglobulins IGG and IGM.;journal of medical virology ; volume 91, issue 1;31 august 2018.
41. Xia J, Zeng H, Liu L, Zhang Y, Liu P, Geng J, Wang L, Zhuang H. Swine and rabbits are the main reservoirs of hepatitis E virus in China: detection of HEV RNA in feces of farmed and wild animals;archives of virology 160;26 august 2015.
42. Aggarwal R. Hepatitis E: clinical presentation in disease-endemic areas and diagnosis;seminar on liver disease;2013; DOI: 10.1055/s-0033-1338112
43. Niraj J. Shah; Amor Royer; Savio John;Statpearls; alcoholic hepatitis; January 2, 2023; [Internet];. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470217
44. https://www.researchgate.net/figure/Characteristic-histological-findings-in-alcoholic-hepatitis-Macrovesicular-steatosis-is_fig3_332755946
45. Alcoholic hepatitis [Internet]. Mayo Foundation for Medical Education and Research; 2020 [cited 2023 Jul 13]. Available from: https://www.mayoclinic.org/diseases-conditions/alcoholic-hepatitis/symptoms-causes/syc-20351388
46. hepatitis/alcoholic-hepatitis ; https://www.hopkinsmedicine.org/health/conditions-and-diseases/
47. https://undefined.photos/photo-gallery/how-do-you-get-autoimmune-liver-disease
48. Autoimmune hepatitis [Internet]. Mayo Foundation for Medical Education and Research; 2022 [cited 2023 Jul 13]. Available from: https://www.mayoclinic.org/diseases-conditions/autoimmune-hepatitis/symptoms-causes/syc-20352153
49. Joseph T. Dipiro, 6th Edition, Pharmacotherapy: A Pathophysiologic Approach, Pages 713–720.
50. O’Grady JG. Acute liver failure. Postgrad Med J 2006,81:143-54.